Investigator-Initiated Studies
Investigator-Initiated Studies supports physicians and researchers conducting studies of AbbVie products and therapeutic interests to expand scientific knowledge and inform patient care.
Funder: AbbVie
Due Dates: Rolling (IIS applications)
Funding Amounts: Financial assistance and/or product support
Summary: Supports investigator-sponsored research involving AbbVie products and therapeutic interests to advance scientific knowledge and inform patient care.
Key Information: Support requires a research agreement fully executed by both parties.
Description
AbbVie’s Investigator-Initiated Studies (IIS) program supports academic and community-based physicians and researchers worldwide conducting their own research. The program aims to expand understanding of AbbVie products and their potential applications, generate evidence that informs patient care, and spark further disease-related research.
Research interests span preclinical, clinical, translational, and real-world studies across aesthetics, eye care, immunology, neuroscience, oncology, and specialty medicine. Priorities include disease mechanisms and burden, treatment effectiveness and safety, biomarkers, treatment patterns, patient-reported outcomes, and treatment optimization. Several areas emphasize unmet medical needs, understudied populations, health disparities, diagnostic and monitoring tools, care models, and treatment’s clinical and economic impact.
